Multi-Modal Assessment of Long-Term Erythropoietin Treatment after Neonatal Hypoxic-Ischemic Injury in Rat Brain

Erythropoietin (EPO) has been recognized as a neuroprotective agent. In animal models of neonatal brain injury, exogenous EPO has been shown to reduce lesion size, improve structure and function. Experimental studies have focused on short course treatment after injury. Timing, dose and length of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Looij, Yohan, Chatagner, Alexandra, Quairiaux, Charles, Gruetter, Rolf, Hüppi, Petra S., Sizonenko, Stéphane V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995802/
https://www.ncbi.nlm.nih.gov/pubmed/24755676
http://dx.doi.org/10.1371/journal.pone.0095643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995802/
https://www.ncbi.nlm.nih.gov/pubmed/24755676
http://dx.doi.org/10.1371/journal.pone.0095643

Ejemplares similares